ZVRA (STOCKS)
Zevra Therapeutics, Inc. Common Stock
$9.740000
+0.270000 (+2.85%)
Prev close: $9.470000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Neil F. McFarlane
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $570.09M
- Employees
- 59
- P/E (TTM)
- 6.99
- P/B (TTM)
- 3.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.21 | $0.05 | +0.1590 | +311.76% |
|
Sep 2025 (Q3)
|
$-0.01 | $-0.04 | +0.0257 | +71.99% |
|
Jun 2025 (Q2)
|
$1.21 | $1.53 | -0.3178 | -20.80% |
|
Mar 2025 (Q1)
|
$-0.06 | $-0.19 | +0.1304 | +68.49% |
Financial Statements
| Revenues | $106.47M |
| Benefits Costs and Expenses | $19.79M |
| Costs And Expenses | $90.36M |
| Nonoperating Income/Loss | $149.62M |
| Operating Expenses | $169.41M |
| Selling, General, and Administrative Expenses | $77.62M |
| Other Operating Expenses | $91.80M |
| Operating Income/Loss | -$62.94M |
| Income/Loss From Continuing Operations After Tax | $83.23M |
| Income/Loss From Continuing Operations Before Tax | $86.68M |
| Income Tax Expense/Benefit | $3.45M |
| Income Tax Expense/Benefit, Current | $13.30M |
| Income Tax Expense/Benefit, Deferred | -$9.85M |
| Net Income/Loss | $83.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $83.23M |
| Net Income/Loss Available To Common Stockholders, Basic | $77.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $5.64M |
| Preferred Stock Dividends And Other Adjustments | $5.64M |
| Basic Earnings Per Share | $1.40 |
| Diluted Earnings Per Share | $1.35 |
| Basic Average Shares | 55,311,308 |
| Diluted Average Shares | 57,262,715 |
| Assets | $284.73M |
| Current Assets | $223.01M |
| Inventory | $1.74M |
| Other Current Assets | $221.27M |
| Noncurrent Assets | $61.72M |
| Fixed Assets | $489.00K |
| Intangible Assets | $6.42M |
| Other Non-current Assets | $54.81M |
| Liabilities | $130.07M |
| Current Liabilities | $39.28M |
| Accounts Payable | $2.48M |
| Other Current Liabilities | $36.80M |
| Noncurrent Liabilities | $90.80M |
| Long-term Debt | $61.93M |
| Other Non-current Liabilities | $28.87M |
| Equity | $154.66M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $154.66M |
| Liabilities And Equity | $284.73M |
| Net Cash Flow From Operating Activities | -$1.60M |
| Net Cash Flow From Operating Activities, Continuing | -$1.60M |
| Net Cash Flow From Investing Activities | $18.13M |
| Net Cash Flow From Investing Activities, Continuing | $18.13M |
| Net Cash Flow From Financing Activities | $12.06M |
| Net Cash Flow From Financing Activities, Continuing | $12.06M |
| Net Cash Flow | $28.59M |
| Net Cash Flow, Continuing | $28.59M |
| Comprehensive Income/Loss | $81.83M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $81.83M |
| Other Comprehensive Income/Loss | $81.83M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.40M |